title: Cochrane Musculoskeletal Group review: acute gout. Steroids or NSAIDs? Let this overview from the Cochrane Group help you decide what's best for your patient.
authors.affiliation: Menzies Research Institute, Private Bag 23, Hobart, Tasmania 7001, Australia. Tania.Winzenberg@utas.edu.au
authors.forename: Tania
authors.initials: T
authors.lastname: Winzenberg
authors.forename: Rachelle
authors.initials: R
authors.lastname: Buchbinder
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005194:Family Practice / Q000592:standards / Q000639:trends; D005260:Female; D005500:Follow-Up Studies; D006073:Gout / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D017060:Patient Satisfaction; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D013256:Steroids / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D013256:Steroids